Results 121 to 130 of about 3,725 (244)
Is there an optimal scan time for 6-[F-18]fluoro-L-DOPA PET in pheochromocytomas and paragangliomas?
, 2012 To define the appropriate scan time for fluorine-18-labeled dihydroxyphenylalanine (F-18 DOPA) PET in oncological imaging of pheochromocytomas and ...Neumann, Hartmut P H, Boedeker, Carsten C, Brink, Ingo, Boedeker, Carsten Christof, Neumann, Hartmut P. H., Hentschel, Michael, Rottenburger, Christof +6 morecore +1 more sourceGCH1 p.Ser80Asn Confers Risk for Parkinson's Disease in East Asian Populations
Movement Disorders, EarlyView.Abstract Introduction
GCH1 has been implicated in Parkinson's disease (PD), but its risks variants and associations are not well defined. Objectives
Our goal was to investigate the clinical relevance and PD risk associated with the GCH1 p.Ser80Asn variant.Yi Wen Tay, Andrew Leslie Lee, Jie Ping Schee, Chin‐Hsien Lin, Eng King Tan, Jung Hwan Shin, Pin‐Shiuan Chen, Sung‐Pin Fan, Cheng‐Hsuan Li, Ebonne Yu Lin Ng, Han Joon Kim, Beomseok Jeon, Sulev Koks, Huyen Thi Thanh Vu, Kin Ying Mok, Yi Ting Lim, Mohd Salahuddin Kamaruddin, Tzi Shin Toh, Hans Xing Ding, Anis Nadhirah Khairul Anuar, Norlisah Ramli, Ignacio J. Keller Sarmiento, Maria Teresa Periñan, Zih‐Hua Fang, Lara M. Lange, Kishore R. Kumar, Soraya Bardien, Joanne Trinh, Enza Maria Valente, SG10K_Health Consortium, the Global Parkinson's Genetics Program (GP2), Peter Heutink, Katja Lohmann, Christine Klein, Niccolò E. Mencacci, Shen‐Yang Lim, Azlina Ahmad‐Annuar, Ai Huey Tan +37 morewiley +1 more sourceInvestigation of Parkinsonism‐Associated Genes in a Large Cohort of Individuals with Early‐Onset or Familial Predominant Parkinsonism
Movement Disorders, EarlyView.Abstract Background
A study of a large cohort, including early‐onset or familial patients with Parkinson's disease (PD), has deciphered the contribution of known PD genes. However, many other genes, thereafter labeled parkinsonism‐associated genes (PAG), are associated with other neurological conditions in which parkinsonism is sometimes reported ...Kilian Rousvoal, Guillaume Cogan, Christelle Tesson, Lionel Arnaud, Matheus Gomes Ferreira, Salmo Raskin, Guilherme Lourenço de Macedo, Sarah Meftahi, Emmanuel Roze, Louise‐Laure Mariani, Hicham El Otmani, Ahmed Bouhouche, Valerie Fraix, Florence Cormier‐Desquaire, Fabienne Ory‐Magne, Elena Moro, Hasmet Hanagasi, Chokri Mhiri, Mustapha Benmahdjoub, Sofiane A. Bouchetara, Tatiana Usenko, Irina Miliukhina, Mathieu Anheim, Caroline Giordana, Ana Marques, Wassilos G. Meissner, David Devos, Basar Bilgic, Ebba Lohman, Aurélie Méneret, Graziella Mangone, Sara Sambin, Lisa Welment, Melanie Ferrien, Gatepe Kodjovi, Aymeric Lanore, Thomas Courtin, Ludmila Jornea, Sylvie Forlani, Yannick Marie, Marie Coutelier, Paul‐Alexandre Pfeiffer, Charlotte Beal, Bertrand Degos, Katty Larcher, Fanny Casse, Fabienne Clot, Gwendoline Dupont, Frédérique Flucher, Alexandra Foubert‐Samier, Philippe Girard, Pauline Prin, Clarisse Scherer Gagou, Marie‐Laure Welter, Andy Singleton, Marie Vidailhet, David Grabli, François Viallet, Luc Defebvre, Francois Tison, Stephane Thobois, Pascal Derkinderen, Claire Thiriez, Philippe Damier, Franck Durif, Alexandra Dürr, Christine Tranchant, Sofya Pchelina, Mohammed Arezki, Riadh Gouider, Murat Emre, Olivier Rascol, Traki Benhassine, Hélio Afonso Ghizoni Teive, Eric LeGuern, Jean‐Christophe Corvol, on behalf of the NS‐PARK Cohort Study Group, Suzanne Lesage, Alexis Brice, on behalf of the PDG group +79 morewiley +1 more sourceNutritional management, dietary intervention, and long‐term monitoring in pediatric Prader–Willi syndrome: A 3‐year case‐based clinical observation
Nutrition in Clinical Practice, EarlyView.Abstract
Nutritional management is fundamental in Prader–Willi syndrome (PWS), but longitudinal data from routine pediatric practice are limited. We describe a 3‐year nutritional follow‐up of a boy with PWS complicated by obesity, insulin resistance, dyslipidemia, hyperuricemia, and fatty liver.Peipei Chen, Hui Pan, Wei Chenwiley +1 more sourceLevodopa and Melanoma: Practical Recommendations for Parkinson's Disease—International Parkinson and Movement Disorder Society Scientific Issues Committee Viewpoint
Movement Disorders Clinical Practice, EarlyView.Giorgia Sciacca, Inas Elsayed, Santiago Perez‐Lloret, Tiago F. Outeiro, Vivek K. Unni, Jeffery H. Kordower, Daniela Berg, Lorraine V. Kalia, on behalf of the MDS Scientific Issues Committee, Jane Alty, Alexander Balck, Daniela Berg, Per Borghammer, Inas Elsayed, Yue Huang, Walaa Kamel Elsayed, Jeffrey Kordower, Alexander Lehn, Michele Matarazzo, Tiago Mestre, Tiago Outeiro, Gian Pal, Santiago Perez Lloret, Roopa Rajan, Sephira Ryman, Giorgia Sciacca, Per Svenningsson, Lorraine Kalia +27 morewiley +1 more sourceRepurposing antimicrobial agents for neuroprotection: Mechanisms, clinical potential, and challenges
Neuroprotection, EarlyView.Antimicrobial agents exert neuroprotective effects through modulation of interconnected pathways. Tetracyclines, macrolides, antimalarial agents, sulfones, and antiparasitic agents suppress neuroinflammation, oxidative stress, and apoptosis while preserving mitochondrial function and neurotransmission.Mohammad Amin Manavi, Mohammadreza Salehi, Razieh Mohammad Jafari, Ramin Goudarzi, Saman Khosravi, Ahmad Reza Dehpour +5 morewiley +1 more sourceAdult‐Onset Dystonia Related to PRKRA (DYT16): A Predictor of Favorable Deep Brain Stimulation Outcome
Movement Disorders Clinical Practice, EarlyView.Ingrid Lorena da Silva Gomes, Eduardo Drews Amorim, Juan Sebastián Sánchez León, Thomas Hugentobler Schlickmann, Yuri Ferreira Felloni Borges, Artur Francisco Schumacher Schuh, Daniel Teixeira‐dos‐Santos, Sheila Trentin, Thais Lampert Monte, Bruno Samuel Fraiman de Oliveira +9 morewiley +1 more source